Pediatric perioperative fluid management

Amit Mathew1, Ekta Rai1

  • 1Department of Anaesthesia, Christian Medical College, Vellore, Tamil Nadu, India.

Insights

Pediatric perioperative fluid management requires individualized care, moving beyond outdated formulas. Current evidence supports tailored approaches to prevent serious complications in critically ill children.

Area of Science:

  • Pediatric Anesthesiology
  • Pediatric Critical Care Medicine
  • Intravenous Fluid Therapy

Background:

  • Appropriate fluid management is crucial for tissue perfusion and homeostasis in perioperative and critically ill children.
  • The heterogeneity of the pediatric population necessitates individualized fluid management strategies.
  • Traditional fluid calculation formulas, like the Holiday and Segar, are based on outdated studies and raise concerns about potential complications such as hyponatremia and hyperglycemia.

Purpose of the Study:

  • To provide a historical perspective on pediatric fluid management.
  • To present a current evidence-based approach to perioperative fluid management in children.
  • To address concerns regarding complications associated with traditional fluid therapy methods.

Main Methods:

  • A comprehensive literature search was conducted using PubMed.
  • Keywords included 'children', 'intravenous fluid therapy', 'crystalloids', 'colloids', 'fluid homeostasis', 'blood loss', 'estimation of blood loss', 'blood loss management', and 'perioperative fluid'.
  • Articles were reviewed to synthesize historical and current evidence.

Main Results:

  • The Holiday and Segar formula, widely used for decades, is based on studies from over 70 years ago on healthy children.
  • Concerns exist regarding the safety of this formula, with potential for hyponatremia and hyperglycemia, leading to neurological damage or mortality.
  • A shift towards individualized, physiology-based fluid management is indicated.

Conclusions:

  • Perioperative fluid management in children must consider individual physiology, pathology, and specific needs.
  • Outdated fluid calculation methods may lead to adverse outcomes.
  • An evidence-based, tailored approach is essential for optimizing fluid therapy in pediatric patients.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
34
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
41
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
54
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
33
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
213
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
34